Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Neeley

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The Journal of Heredity|November 1, 1971
Some environmental influences on metafemale viability in Drosophila melanogasterJ C Neeley
Hospitals|January 1, 1984
Hospital economic forecastK A Johnson, C Neeley
Hospitals|October 1, 1983
A service of hospitals and Merrill Lynch Economics, IncK A Johnson, C Neeley
Psychological Assessment|November 3, 2005
Recipient-provider agreement on enacted support, perceived support, and provider personalityJay L Cohen, Brian Lakey, Kathy Tiell, et al.
Case Reports in Neurological Medicine|May 19, 2016
Profound Autonomic Instability Complicated by Multiple Episodes of Cardiac Asystole and Refractory Bradycardia in a Patient with Anti-NMDA EncephalitisStephanie R Mehr, Roy C Neeley, Melissa Wiley, et al.
The Prostate|October 19, 2002
Antigen-specific tumor vaccine efficacy in vivo against prostate cancer with low class I MHC requires competent class II MHCYilin C Neeley, Kevin T McDonagh, Willem W Overwijk, et al.
The Prostate|February 28, 2008
Partially circumventing peripheral tolerance for oncogene-specific prostate cancer immunotherapyYilin C Neeley, Mohamed S Arredouani, Brent Hollenbeck, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|August 8, 2017
Student Perspectives on Oncology Curricula at United States Medical SchoolsBrandon C Neeley, Daniel W Golden, Jeffrey V Brower, et al.
Military Medicine|December 5, 2021
Using Catchment Population to Estimate Sporadic Creutzfeldt-Jakob Disease IncidenceBrandon C Neeley, Faraze A Niazi, Michael A Ebbert, et al.
Cancer Immunology, Immunotherapy : CII|February 13, 2008
Fas-mediated T cell deletion potentiates tumor antigen-specific tolerance in a mouse model of prostate cancerStephanie S Tseng-Rogenski, Mohamed S Arredouani, Yilin C Neeley, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Journal of Heredity|November 1, 1971
Some environmental influences on metafemale viability in Drosophila melanogasterJ C Neeley
Hospitals|January 1, 1984
Hospital economic forecastK A Johnson, C Neeley
Hospitals|October 1, 1983
A service of hospitals and Merrill Lynch Economics, IncK A Johnson, C Neeley
Psychological Assessment|November 3, 2005
Recipient-provider agreement on enacted support, perceived support, and provider personalityJay L Cohen, Brian Lakey, Kathy Tiell, et al.
Case Reports in Neurological Medicine|May 19, 2016
Profound Autonomic Instability Complicated by Multiple Episodes of Cardiac Asystole and Refractory Bradycardia in a Patient with Anti-NMDA EncephalitisStephanie R Mehr, Roy C Neeley, Melissa Wiley, et al.
The Prostate|October 19, 2002
Antigen-specific tumor vaccine efficacy in vivo against prostate cancer with low class I MHC requires competent class II MHCYilin C Neeley, Kevin T McDonagh, Willem W Overwijk, et al.
The Prostate|February 28, 2008
Partially circumventing peripheral tolerance for oncogene-specific prostate cancer immunotherapyYilin C Neeley, Mohamed S Arredouani, Brent Hollenbeck, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|August 8, 2017
Student Perspectives on Oncology Curricula at United States Medical SchoolsBrandon C Neeley, Daniel W Golden, Jeffrey V Brower, et al.
Military Medicine|December 5, 2021
Using Catchment Population to Estimate Sporadic Creutzfeldt-Jakob Disease IncidenceBrandon C Neeley, Faraze A Niazi, Michael A Ebbert, et al.
Cancer Immunology, Immunotherapy : CII|February 13, 2008
Fas-mediated T cell deletion potentiates tumor antigen-specific tolerance in a mouse model of prostate cancerStephanie S Tseng-Rogenski, Mohamed S Arredouani, Yilin C Neeley, et al.
Pageof 2